![Rainer Strohmenger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rainer Strohmenger
Direktor/Vorstandsmitglied bei
AMBOSS GmbH
Profil
Dr. Rainer Strohmenger is a Managing Partner at Wellington Partners GmbH.
He is on the Board of Directors at iOmx Therapeutics AG, AMBOSS GmbH and Quanta Dialysis Technologies Ltd. Dr. Strohmenger was previously employed as a Member-Supervisory Board by Definiens AG, a Member-Supervisory Board by Genticel SA, a Member-Supervisory Board by Ambu Innovation GmbH, an Independent Director by Oxford Immunotec Global Ltd., and a Non-Executive Director by Oxford Immunotec Ltd. He also served on the board at Implanet SA, Immatics Biotechnologies GmbH, mtm laboratories AG and Sovicell GmbH.
He received his graduate degree from Ludwig-Maximilians-Universität München and a doctorate degree from Ludwig-Maximilians-Universität München.
Aktive Positionen von Rainer Strohmenger
| Unternehmen | Position | Beginn |
|---|---|---|
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Europe, the United States and Asia. The firm focuses on biotechnology, therapeutics, medical devices, diagnostics and digital health sectors. It provides financing for early and growth stage transactions with an investments size of EUR 2 - 20 million. The firm also acts as lead investor. | Private Equity Investor | 01.12.1997 |
Quanta Dialysis Technologies Ltd.
 Quanta Dialysis Technologies Ltd. Medical SpecialtiesHealth Technology Develops hemodialysis systems | Direktor/Vorstandsmitglied | - |
AMBOSS GmbH
 AMBOSS GmbH Packaged SoftwareTechnology Services Offers medical knowledge and learning platform | Direktor/Vorstandsmitglied | - |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Direktor/Vorstandsmitglied | 25.08.2020 |
Ehemalige bekannte Positionen von Rainer Strohmenger
| Unternehmen | Position | Ende |
|---|---|---|
| IMPLANET SA | Direktor/Vorstandsmitglied | 24.03.2016 |
| OXFORD IMMUNOTEC GLOBAL PLC | Direktor/Vorstandsmitglied | 21.11.2013 |
Oxford Immunotec Ltd.
 Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Develops and sells medical diagnostic products | Direktor/Vorstandsmitglied | 02.10.2013 |
mtm laboratories AG
 mtm laboratories AG Medical SpecialtiesHealth Technology Develops and manufactures diagnostic and detection products for cervical cancer | Direktor/Vorstandsmitglied | - |
Definiens AG
 Definiens AG Packaged SoftwareTechnology Services Develops and markets biomedical imaging and data analysis software solutions | Direktor/Vorstandsmitglied | - |
Ausbildung von Rainer Strohmenger
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
73
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Oxford Immunotec Global Ltd.
 Oxford Immunotec Global Ltd. Medical SpecialtiesHealth Technology Provides diagnostic and innovative tests in the field of immunology | Health Technology |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Europe, the United States and Asia. The firm focuses on biotechnology, therapeutics, medical devices, diagnostics and digital health sectors. It provides financing for early and growth stage transactions with an investments size of EUR 2 - 20 million. The firm also acts as lead investor. | Finance |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
mtm laboratories AG
mtm laboratories AG Medical SpecialtiesHealth Technology Develops and manufactures diagnostic and detection products for cervical cancer | Health Technology |
Sovicell GmbH
 Sovicell GmbH Pharmaceuticals: MajorHealth Technology Provides drug discovery services | Health Technology |
Oxford Immunotec Ltd.
Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Develops and sells medical diagnostic products | Health Technology |
Definiens AG
Definiens AG Packaged SoftwareTechnology Services Develops and markets biomedical imaging and data analysis software solutions | Technology Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Implanet SA
 Implanet SA Medical SpecialtiesHealth Technology Designs and manufactures surgical implants | Health Technology |
Ambu Innovation GmbH
 Ambu Innovation GmbH Medical SpecialtiesHealth Technology Develops and distributes disposable endoscopic products in the field of gastroenterology | Health Technology |
Genticel SA
 Genticel SA BiotechnologyHealth Technology Develops vaccines for patients infected with human papillomavirus | Health Technology |
Quanta Dialysis Technologies Ltd.
Quanta Dialysis Technologies Ltd. Medical SpecialtiesHealth Technology Develops hemodialysis systems | Health Technology |
AMBOSS GmbH
AMBOSS GmbH Packaged SoftwareTechnology Services Offers medical knowledge and learning platform | Technology Services |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Health Technology |
